CENTRE FOR RESEARCH IN HEALTH AND DEVELOPMENT LIMITED
SUITE G04, 1 QUALITY COURT, CHANCERY LANE, LONDON  WC2A 1HR- Active
- PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
- Company No. 14134567
- Last Updated: 01 Mar 2024
Company Profile
CENTRE FOR RESEARCH IN HEALTH AND DEVELOPMENT LIMITED was incorporated on Thursday, May 26, 2022 as a PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital) with registered address in LONDON. CENTRE FOR RESEARCH IN HEALTH AND DEVELOPMENT LIMITED has the status: Active and it's listed in the following category: Research and experimental development on social sciences and humanities. This PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital) has been operating for 2 years 8 months and 29 days.
Name | CENTRE FOR RESEARCH IN HEALTH AND DEVELOPMENT LIMITED |
---|---|
Company number | 14134567 |
Company type | PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital) |
Incorporation date | 26 May 2022 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
SUITE G04 1 QUALITY COURT, CHANCERY LANE LONDON WC2A 1HR |
---|---|
Country Of Origin | ENGLAND |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Noreen Mdege Nationality: British |
Dates: Thursday, May 26, 2022 - present
ownership of shares 75 to 100 percent
|
Accounts and Confirmation
Type of accounts | TOTAL EXEMPTION FULL |
---|---|
End of financial Year | 31 May |
Next annual accounts due | 28 February 2025, (3 days left) |
Latest accounts | 31 May 2023 |
Next confirmation statement due | 23 June 2023 |
Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against CENTRE FOR RESEARCH IN HEALTH AND DEVELOPMENT LIMITED.
Previous Names
Name | Change Date |
---|---|
CENTRE FOR RESEARCH IN HEALTH AND DEVELOPMENT LIMITED | 26 May 2022 |